Loading company…
Won a federal SBIR/STTR research award from NSF and other federal agencies.
Sanguine Biosciences, Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $224,981 in 2019. These are non-dilutive federal research grants, not equity financing. The company is based in Sherman Oaks, California.
4 rounds · latest SBIR Phase I award (NSF), Feb 2019
Sign in to see 4 rounds.
Sign inSign in to see 4 investors.
Sign inSanguine Biosciences, Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Sanguine Biosciences, Inc..
Add diversity data